The government may approve acquisitions of local drugmakers by global firms on a case-by-case basis on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. Multinationals may have to move buyout proposals through the Foreign Investment Promotion Board (FIPB), allowing the government to understand the firm's rationale for buying a...

The Supreme Court today wondered whether faulty development practices were the “root cause” of the Maoist insurgency in Chhattisgarh, and asked the state how many agreements it had signed with multi-nationals and how it was using the state’s financial resources. It also asked the state government to explain how and under what rules it recruited and armed the Koya commandos — special police officers (SPOs) fighting the Maoists. “How many MoUs (memoranda...

DEALS WITH MULTINATIONALS AND OTHER BIG AGRIBUSINESS COMPANIES A wide range of farmers’ organisations, Gandhian organisations, people’s movements and NGOs have united to oppose a series of disturbing agreements which the Rajasthan Government reached with various multinational and other agribusiness companies including Monsanto. These agreements, which greatly increase the control and influence of these companies over the agriculture sector in India’s biggest State (in terms of area), have proved so controversial...

By all indications, FDI in multi-brand retail is a fait accompli. Or so we have been told time and again by everyone, the PM downward. The “question is at what point of time it should be done”. This remark from Pranab Mukherjee in a post-budget TV interview may have revealed that the debate has moved beyond whether to permit FDI in multi-brand retailing—the lifeline of small- and medium-sized neighbourhood stores....

The government today said multi national companies (MNCs) are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment. In a written reply to the Lok Sabha, Minister of State for Commerce and Industry Jyotiraditya Scindia said: "A concerted campaign against India pharma industry has been launched by MNCs whose interests are getting adversely impacted due to increasing...